Login / Signup

Effectiveness of Switching to Subcutaneous Infliximab in Ulcerative Colitis Patients Experiencing Intravenous Infliximab Failure.

June Hwa BaeJung-Bin ParkJi Eun BaekSeung Wook HongSang Hyoung ParkDong-Hoon YangByong Duk YeSeung Wook HongSeung-Jae MyungSuk-Kyun YangSung Wook Hwang
Published in: Gut and liver (2024)
In UC patients who experience IV infliximab failure during maintenance treatment, switching to SC infliximab may be a promising option because of better efficacy and safety.
Keyphrases
  • ulcerative colitis
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • randomized controlled trial
  • chronic kidney disease
  • systematic review
  • prognostic factors
  • peritoneal dialysis
  • high dose
  • low dose